Read + Share
O'Sullivan H, Popat S. Atezolizumab in patients with advanced non-small-cell lung cancer who are
platinum-doublet ineligible. Lancet 2023 Jul 6:S0140-6736(23)00807-3. doi: 10.1016/S0140-6736(23)00807.
PMID: 37423230
|
 |
|
O'Sullivan H, Popat S. Atezolizumab in patients with advanced non-small-cell lung cancer who are
platinum-doublet ineligible. Lancet 2023 Jul 6:S0140-6736(23)00807-3. doi: 10.1016/S0140-6736(23)00807.
PMID: 37423230
|
|
|
|